Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the William Blair Growth Stock Conference on Tuesday, June 13, 2017, at 10:50 a.m. CDT in Chicago, IL.

A live audio webcast for this event will be available in the Investors section of the Glaukos website at http://investors.glaukos.com.

About Glaukos

Glaukos (www.glaukos.com) is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent®, its first MIGS device, in the United States in July 2012 and is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression. The company believes the iStent, measuring 1.0 mm long and 0.33 mm wide, is the smallest medical device ever approved by the FDA.

Glaukos CorporationSheree AronsonVP, Investor Relations(949) 367-9600 ext 371saronson@glaukos.com

Glaukos (NYSE:GKOS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Glaukos Charts.
Glaukos (NYSE:GKOS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Glaukos Charts.